Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$25K Buy
3,544
+1,441
+69% +$11.3K ﹤0.01% 7708
2014
Q2
$18K Sell
2,103
-1,677
-44% -$14.4K ﹤0.01% 8209
2014
Q1
$34K Sell
3,780
-1,666
-31% -$15.3K ﹤0.01% 7354
2013
Q4
$56K Buy
5,446
+3,796
+230% +$30.4K ﹤0.01% 6806
2013
Q3
$10K Hold
1,650
﹤0.01% 8811
2013
Q2
$10K Buy
+1,650
New +$8.85K ﹤0.01% 8622

Other funds holding IRIX

UBS's IRIX Position: Q3 2014 in Review

UBS increased its IRIDEX (IRIX) stake by 69% in Q3 2014, buying an estimated $11.3K and bringing the position to 3,544 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #7708.

UBS first reported a position in IRIX in Q2 2013 and has held it in 6 quarters since. The position peaked at $56K in Q4 2013. 30 funds tracked by Wall St. Rank hold IRIX as of Q3 2014.

  • UBS held 3,544 shares of IRIDEX worth $25K as of Q3 2014.
  • UBS bought 1,441 IRIDEX shares in Q3 2014, an estimated $11.3K.
  • IRIDEX made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7708 holding.
  • UBS first reported a position in IRIDEX in Q2 2013 and has held it in 6 quarters since.
  • UBS's IRIDEX position peaked at $56K in Q4 2013.
  • 30 funds tracked by Wall St. Rank held IRIDEX as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.